Konecny, G <br/><br/>
Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.  [electronic resource] 

 -  Gynecologic oncology  May 2000 
 - 258-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0090-8258 
<br/><br/><label>Standard No.: </label>10.1006/gyno.2000.5728  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphate--blood<br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Carboplatin--pharmacology<br/>Carcinoma--drug therapy<br/>Cisplatin--pharmacology<br/>Cyclophosphamide--pharmacology<br/>Drug Resistance, Neoplasm<br/>Drug Screening Assays, Antitumor<br/>Epirubicin--pharmacology<br/>Female<br/>Humans<br/>Ovarian Neoplasms--drug therapy<br/>Paclitaxel--pharmacology<br/>Predictive Value of Tests<br/>Regression Analysis<br/>Sensitivity and Specificity<br/>Survival Analysis<br/>Tumor Cells, Cultured